{
 "context": "The following article called 'Spectrum\u2019s Shrotriya Says Sales Will Match or Beat the Previous Quarter\u2019s' was published on 2012-01-26. The body of the article is as follows:\n    \nSpectrum Pharmaceuticals Inc. (SPPI) \u2019s\nfourth-quarter sales will match or beat the previous quarter\u2019s\nrevenue, Chief Executive Officer Rajesh Shrotriya said.  \u201cWe will maintain our revenue, the same or better\u201d than\nSpectrum\u2019s third-quarter sales of $51 million, Shrotriya said\ntoday in a telephone interview.  Spectrum, of  Irvine , California, declined 6.6 percent to\n$14 at 1:49 p.m. New York time in the biggest intraday drop\nsince Dec. 9. \u201cRumor and perception\u201d that the company\u2019s\nfourth-quarter revenue will fall short of third-quarter sales\nmay have caused the decline, he said.  The company\u2019s stock has had a \u201ctremendous run\u201d in the\npast year, and \u201cwe\u2019re not hearing anything that would have us\nworry that it\u2019s being derailed,\u201d Reni Benjamin, an analyst with\nRodman & Renshaw in  New York , said today by telephone. The\nshares had more than doubled in the year before today.  To contact the reporter on this story:\nMolly Peterson in Washington at \n mpeterson9@bloomberg.net   To contact the editor responsible for this story:\nAdriel Bettelheim at \n abettelheim@bloomberg.net\n\n    The day before the article was published, the stock price of Spectrum Pharmaceuticals, Inc. was 14.789955139160156 and the day after the article was published, the stock price of Spectrum Pharmaceuticals, Inc. was ",
 "expected": "13.813167572021484",
 "date": "2012-01-26",
 "ticker": "SPPI",
 "company": "Spectrum Pharmaceuticals, Inc.",
 "url": "http://www.bloomberg.com/news/2012-01-26/spectrum-s-shrotriya-says-sales-will-match-or-beat-the-previous-quarter-s.html"
}